Navigation Links
Mirati Therapeutics Reports Third Quarter 2013 Financial Results
Date:11/12/2013

SAN DIEGO, Nov. 12, 2013 /PRNewswire/ -- Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX) today reported financial results for the third quarter and nine months ended September 30, 2013.

Recent Corporate Highlights

  • Completed financing that generated net proceeds of $53.0 million
  • Strengthened our world-class precision medicine team with addition of Isan Chen to the position of chief medical and development officer
  • Progressed new formulations for MGCD265 with a goal of initiating dose expansion cohorts in selected patient populations in the first quarter of 2014
  • Initiated development plans for mocetinostat in patients with myelodysplastic syndrome, with a dose confirmation study expected to begin this year and plans to finalize discussions and obtain a special protocol assessment from the FDA for the design of a Phase III trial in the first half of 2014
  • "This has been a year of great progress for Mirati, we completed a successful financing ($53.0 million), built out an extremely accomplished precision medicine team and restructured the corporation, which will allow us to aggressively advance our oncology pipeline," said Dr. Charles Baum, president and CEO of Mirati. "In 2014, we will use the foundation we have built to achieve key milestones in each of our programs. By mid-2014 we plan to have confirmation of clinical activity for MGCD265, our kinase inhibitor program targeting Met, Axl and VEGFR, in selected solid tumor patients with high unmet need and potential accelerated approval registration paths. We also plan to initiate a Phase 1 study with MGCD516, our second multi-target kinase inhibitor program focused on Trk, RET, DDR and EphRs, in cancer patients by mid-2014 and to enter further expansion studies in selected tumor types by the end
    '/>"/>

    SOURCE Mirati Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Mirati Therapeutics Prices Public Offering Of Common Stock
    2. Sorrento Therapeutics Adopts Stockholder Rights Plan
    3. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
    4. Shield Therapeutics Files Investigational New Drug Application for ST10 for the Treatment of Iron Deficiency in Chronic Kidney Disease
    5. Cara Therapeutics Files Registration Statement for Proposed Initial Public Offering
    6. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    7. Echo Therapeutics Announces Third Quarter 2013 Financial Results
    8. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
    9. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
    10. PDL BioPharma Provides $70 Million in Financing to Durata Therapeutics
    11. PTC Therapeutics to Present at Credit Suisse Annual Health Care Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2014)... Nov. 24, 2014 Luoxis Diagnostics, Inc., ... AMPE), today announced the presentation of three clinical ... as a broadly applicable and robust research tool ... body in response to injury, illness, or stress.  ... collaboration with Luoxis, academic and pharmaceutical research partners, ...
    (Date:11/24/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... today that Sergio Traversa , chief executive officer, ... Event" Micro-Cap Growth Conference on Wednesday, December 3, 2014.  ... Bel Air Hotel, which is located at 11461 Sunset ... The presentation is scheduled for 8:30 a.m. ...
    (Date:11/24/2014)... , Nov. 24, 2014  AiCure, an artificial ... technology to monitor medication ingestion, has announced the ... and intervene with patients receiving medication as maintenance ... overdoses from prescription opiates have quadrupled in the ... per year than heroin, cocaine and benzodiazepines combined. ...
    Breaking Medicine Technology:Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5Relmada Therapeutics To Present At LD MICRO Conference 2Can artificial intelligence solve the $55 billion problem of opioid abuse? 2
    (Date:11/26/2014)... November 26, 2014 Increasing demand ... include image guided surgeries has paved way for ... Rising incidence of various types of cancers and ... increase in demand for these owing to their ... contrast media injectors market can also be attributed ...
    (Date:11/26/2014)... German scientists say carbon-based synthetic molecules ... mesothelioma that looks and acts similar to asbestos-induced mesothelioma. ... the research. Click here to read it now. ... and Experimental Medicine in Hannover injected 500 lab rats ... rats eventually developed mesothelioma , how quickly it ...
    (Date:11/26/2014)... For its December issue , ... Report on Blue Cross and Blue Shield Plans* interviewed ... varied strategies the two Blues plans are implementing in ... for sleep apnea, ranging from brick-and-mortar retail stores to ... to increased rates of a variety of serious disorders, ...
    (Date:11/26/2014)... (PRWEB) November 26, 2014 With Thousand ... of dollars, the prosthodontists at the Anacapa Dental Art Institute ... dental procedures can be daunting for some. , That is ... the procedures they offer. , “No dentist wants cost to ... set of teeth,” said Dr. Mamaly Reshad, partner in the ...
    (Date:11/26/2014)... the video interviewing specialist, has today announced the appointment ... Officer, in addition to the formal opening of it’s ... appointed as Chief Operating Officer. He is joined by ... Officer. , Mr Jones is a seasoned tech, media ... with The Walt Disney Company and Adventis where he ...
    Breaking Medicine News(10 mins):Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2
    ... uncovers "biologic treatments", ROSEMONT, Ill., Nov. 3 ... proteins repair fractured bones published in the,November 2008 ... of Orthopaedic,Surgeons ( http://www.jaaos.org/ ) demonstrates that understanding ... improved and less invasive,treatments for fractures., "The ...
    ... Nov. 3 World Champion athlete and health,and ... as a member of the,California Governor,s Council on ... to the student body of NEW Academy Canoga ... healthy lifestyles., (Photo: http://www.newscom.com/cgi-bin/prnh/20081103/AQM074 ), ...
    ... Pa., Nov. 3 BMP Sunstone,Corporation (Nasdaq: BJGP ... plans to release third quarter 2008 financial results on,Monday, ... Company will hold a conference call at 9:00 am ... third quarter 2008 results.,Listeners may access the call by ...
    ... Provider Services Cited as Pivotal to ... Billing Efficiency Statewide, NASHVILLE, Tenn., Nov. 3 ... solutions for the healthcare industry,has been named the electronic ... Hospital Association (MHA). Emdeon was selected,through a competitive bidding ...
    ... $50 million in annual revenue for SXC,s ... 3 /PRNewswire-FirstCall/ - SXC Health Solutions Corp.,("SXC" or ... announces that its,pharmacy benefit management (PBM) division, informedRx, ... of San Mateo (HPSM) valued at more,than $50 ...
    ... seatbelts more common for adolescents illegally at the wheel, study ... if the thought of teenagers driving before they,ve gotten their ... kids are also more likely to drive while drinking or ... they get behind the wheel. , Reporting in the November ...
    Cached Medicine News:Health News:The Biology of Broken Bones Leads to New Treatments 2Health News:The Biology of Broken Bones Leads to New Treatments 3Health News:Laila Ali Debuts as Member of California Governor's Council on Physical Fitness and Sports 2Health News:BMP Sunstone to Report Third Quarter 2008 Financial Results 2Health News:Emdeon Selected by the Maryland Hospital Association to Power the Maryland Transaction Data Interchange 2Health News:SXC Health Solutions announces PBM services agreement with Health Plan of San Mateo 2Health News:Many Unlicensed Teen Drivers Put Safety Last 2Health News:Many Unlicensed Teen Drivers Put Safety Last 3
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: